Zobrazeno 1 - 10
of 183
pro vyhledávání: '"T, de Paulis"'
Autor:
B. L. Trivedi, T. De Paulis, William A. Hewlett, Dennis E. Schmidt, Michael H. Ebert, N. S. Mason
Publikováno v:
European Journal of Medicinal Chemistry. 32:385-396
Summary ( S )-5-Iodo-2,3-dimethoxy- N -(1-azabicyclo[2.2.2]oct-3-yl)benzamide (MIZAC) was prepared from 5-iodo-2,3-dimethoxybenzoyl chloride and ( S )-3-aminoquinuclidine. [ 125 I]Iodode-stannylation of its corresponding 5-tri- n -butyltin derivative
Autor:
I. + Csoeregh, H. Hall, S. O. Oegren, T. Hoegberg, P. Stroem, K. Lundin, B. Stensland, T. De Paulis
Publikováno v:
ChemInform. 22
Publikováno v:
ChemInform. 22
Publikováno v:
ChemInform. 22
Autor:
T. De Paulis, N. El Tayar, T. Hoegberg, Bernard Testa, Ruey-Shiuan Tsai, Pierre-Alain Carrupt
Publikováno v:
ChemInform. 22
Autor:
B. L. Trivedi, Dennis E. Schmidt, William A. Hewlett, Michael H. Ebert, Zhang-Jin Zhang, T. De Paulis
Publikováno v:
ChemInform. 28
Autor:
T. De Paulis, B. L. Trivedi, Dennis E. Schmidt, N. S. Mason, William A. Hewlett, Michael H. Ebert
Publikováno v:
ChemInform. 28
Summary ( S )-5-Iodo-2,3-dimethoxy- N -(1-azabicyclo[2.2.2]oct-3-yl)benzamide (MIZAC) was prepared from 5-iodo-2,3-dimethoxybenzoyl chloride and ( S )-3-aminoquinuclidine. [ 125 I]Iodode-stannylation of its corresponding 5-tri- n -butyltin derivative
Autor:
N. S. Mason, Dennis E. Schmidt, T. De Paulis, Zhang-Jin Zhang, Michael H. Ebert, B. L. Trivedi, William A. Hewlett
Publikováno v:
ChemInform. 29
Autor:
T. De Paulis, Robert M. Kessler, Dennis E. Schmidt, Jeffery A. Clanton, R. M. Baldwin, Mohammed Ansari, Ronald G. Manning
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 29:745-751
(S)-(−)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[123I]iodo-2,3-dimethoxybenzamide (TDP 517) (proposed generic name, [123I]epidepride) is the iodine-123 substituted analogue of isoremoxipride (FLB 457), both of which are very potent dopamine D-2 antago
Publikováno v:
European Journal of Medicinal Chemistry. 25:507-517
A number of substituted 2-methoxybenzamides, with and without 6-hydroxy groups, with 4-piperidinyl side-chains have been synthesized and evaluated for their antidopaminergic properties. The salicylamides were found to require a lipophilic N-substitue